Literature DB >> 12505578

Variation in the utilization of antiarrhythmic drugs in patients with new-onset atrial fibrillation.

Peter Zimetbaum1, Kalon K L Ho, Brian Olshansky, Thomas Hadjis, Robert Lemery, Paul A Friedman, David S Cannom, Xiao Hua Chen, Mark E Josephson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12505578     DOI： 10.1016/s0002-9149(02)03004-7

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  7 in total

1.  Adherence to guideline recommendations for antiarrhythmic drugs in atrial fibrillation.

Authors:  Nancy M Allen LaPointe; Yuliya Lokhnygina; Gillian D Sanders; Eric D Peterson; Sana M Al-Khatib
Journal:  Am Heart J       Date:  2013-09-24       Impact factor: 4.749

2.  Rate versus rhythm control strategies for AF.

Authors:  Brian Olshansky
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-10

Review 3.  Pharmacologic management of atrial fibrillation in the elderly: rate control, rhythm control, and anticoagulation.

Authors:  Seth McClennen; Peter J Zimetbaum
Journal:  Curr Cardiol Rep       Date:  2003-09       Impact factor: 2.931

4.  Healthcare resource utilization and costs associated with recurrent episodes of atrial fibrillation: the FRACTAL registry.

Authors:  Matthew R Reynolds; Vidal Essebag; Peter Zimetbaum; David J Cohen
Journal:  J Cardiovasc Electrophysiol       Date:  2007-04-19

5.  Use Of Rate And Rhythm Control Drugs In Patients Younger Than 65 Years With Atrial Fibrillation.

Authors:  Nancy M Allen LaPointe; Yuliya Lokhnygina; Jacqueline Rimmler; Gillian D Sanders; Eric D Peterson; Sana M Al-Khatib
Journal:  J Atr Fibrillation       Date:  2014-06-30

6.  Amiodarone and risk of death in contemporary patients with atrial fibrillation: Findings from The Retrospective Evaluation and Assessment of Therapies in AF study.

Authors:  Aditya J Ullal; Claire T Than; Jun Fan; Susan Schmitt; Alexander C Perino; Daniel W Kaiser; Paul A Heidenreich; Susan M Frayne; Ciaran S Phibbs; Mintu P Turakhia
Journal:  Am Heart J       Date:  2015-07-26       Impact factor: 4.749

7.  Warfarin vs. apixaban in nonvalvular atrial fibrillation, and analysis by concomitant antiarrhythmic medication use: A national retrospective study.

Authors:  Matthew A Wanat; Xin Wang; Rutugandha Paranjpe; Hua Chen; Michael L Johnson; Marc L Fleming; Susan M Abughosh
Journal:  Res Pract Thromb Haemost       Date:  2019-06-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.